Evidence map›Paper›PMID 32859985›Full record

ArticleScientific reports2020

XRN2 interactome reveals its synthetic lethal relationship with PARP1 inhibition.

Praveen L Patidar, Talysa Viera, Julio C Morales, Naveen Singh, Edward A Motea, Megha Khandelwal, Farjana J Fattah

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Praveen L PatidarDepartment of Chemistry, New Mexico Institute of Mining and Technology, 801 Leroy Pl., Socorro, NM, 87801, USA. Praveen.Patidar@nmt.edu.
Talysa VieraDepartment of Chemistry, New Mexico Institute of Mining and Technology, 801 Leroy Pl., Socorro, NM, 87801, USA.
Julio C MoralesDepartment of Neurosurgery, University of Oklahoma Health Science Center, Oklahoma City, OK, 73104, USA.
Naveen SinghDepartment of Biochemistry and Molecular Biology, Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Edward A MoteaDepartment of Biochemistry and Molecular Biology, Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Megha KhandelwalDepartment of Chemistry, New Mexico Institute of Mining and Technology, 801 Leroy Pl., Socorro, NM, 87801, USA.
Farjana J FattahSimmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
New Mexico Institute of Mining and Technology · USIndiana University – Purdue University Indianapolis · USIndiana University School of MedicineThe University of Texas Southwestern Medical Center · USUniversity of Oklahoma Health Sciences Center · US

Funding

Ku70 Binding Protein-5 (KUB5), a Novel Factor in Nonhomologous End JoiningR01CA139217 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI BOOTHMAN, DAVID A · 2010 to 2014
$1.7M
The Interplay of XRN2 and PARP1 in Preventing R-loop-induced Genomic InstabilityR15GM128071 · NIGMS · NEW MEXICO INST OF MINING & TECHNOLOGY · PI PATIDAR, PRAVEEN · 2018 to 2018
$384k
NCI NIH HHS R01 CA139217NIGMS NIH HHS R15 GM128071
6 · The paper itself

Abstract

Persistent R-loops (RNA-DNA hybrids with a displaced single-stranded DNA) create DNA damage and lead to genomic instability. The 5'-3'-exoribonuclease 2 (XRN2) degrades RNA to resolve R-loops and promotes transcription termination. Previously, XRN2 was implicated in DNA double strand break (DSB) repair and in resolving replication stress. Here, using tandem affinity purification-mass spectrometry, bioinformatics, and biochemical approaches, we found that XRN2 associates with proteins involved in DNA repair/replication (Ku70-Ku80, DNA-PKcs, PARP1, MCM2-7, PCNA, RPA1) and RNA metabolism (RNA helicases, PRP19, p54(nrb), splicing factors). Novel major pathways linked to XRN2 include cell cycle control of chromosomal replication and DSB repair by non-homologous end joining. Investigating the biological implications of these interactions led us to discover that XRN2 depletion compromised cell survival after additional knockdown of specific DNA repair proteins, including PARP1. XRN2-deficient cells also showed enhanced PARP1 activity. Consistent with concurrent depletion of XRN2 and PARP1 promoting cell death, XRN2-deficient fibroblast and lung cancer cells also demonstrated sensitivity to PARP1 inhibition. XRN2 alterations (mutations, copy number/expression changes) are frequent in cancers. Thus, PARP1 inhibition could target cancers exhibiting XRN2 functional loss. Collectively, our data suggest XRN2's association with novel protein partners and unravel synthetic lethality between XRN2 depletion and PARP1 inhibition.

Indexed as

A549 CellsDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA DamageDNA End-Joining RepairDNA RepairDNA ReplicationExoribonucleasesGenomic InstabilityHEK293 CellsHeLa CellsHumansPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) PolymerasesR-Loop StructuresRNA HelicasesDNA-Binding ProteinsExoribonucleasesPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) PolymerasesRNA HelicasesXRN2 protein, human

Identifiers

PMID32859985
PMCPMC7455564
OpenAlexW3082722811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.